<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang K</submitter><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><pagination>100687</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8348308</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2(3)</volume><pubmed_abstract>Carnitine palmitoyltransferase-1 (CPT-1) is a rate-controlling enzyme for long-chain fatty acid oxidation. This manuscript provides protocols for measuring CPT-1-mediated respiration in permeabilized, adherent cell monolayers and mitochondria freshly isolated from tissue, along with examples to assess the potency and specificity of interventions targeting CPT-1. Strengths of the approach include ease, speed, and breadth of analysis, whereas drawbacks include loss of physiological regulation in reductionist systems and indirect assessment of CPT-1 enzymatic activity. For complete details on the use and execution of this protocol, please refer to Divakaruni et al. (2018).</pubmed_abstract><journal>STAR protocols</journal><pubmed_title>Measuring CPT-1-mediated respiration in permeabilized cells and isolated mitochondria.</pubmed_title><pmcid>PMC8348308</pmcid><funding_grant_id>R35GM138003</funding_grant_id><funding_grant_id>P30DK063491</funding_grant_id><funding_grant_id>R35 GM138003</funding_grant_id><pubmed_authors>Doan MT</pubmed_authors><pubmed_authors>Yang K</pubmed_authors><pubmed_authors>Stiles L</pubmed_authors><pubmed_authors>Divakaruni AS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Measuring CPT-1-mediated respiration in permeabilized cells and isolated mitochondria.</name><description>Carnitine palmitoyltransferase-1 (CPT-1) is a rate-controlling enzyme for long-chain fatty acid oxidation. This manuscript provides protocols for measuring CPT-1-mediated respiration in permeabilized, adherent cell monolayers and mitochondria freshly isolated from tissue, along with examples to assess the potency and specificity of interventions targeting CPT-1. Strengths of the approach include ease, speed, and breadth of analysis, whereas drawbacks include loss of physiological regulation in reductionist systems and indirect assessment of CPT-1 enzymatic activity. For complete details on the use and execution of this protocol, please refer to Divakaruni et al. (2018).</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-05T08:50:24.948Z</modification><creation>2025-02-19T01:15:59.243Z</creation></dates><accession>S-EPMC8348308</accession><cross_references><pubmed>34401773</pubmed><doi>10.1016/j.xpro.2021.100687</doi></cross_references></HashMap>